NewsRx

Search our medical news database

Bioengineering

Wright Medical Group, Inc. Announces Japanese Regulatory Approval for CONSERVE(R) Plus Hip Resurfacing System

Published in Lab Law Weekly, November 23rd, 2007

Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced approval of its CONSERVE(R) Plus Hip Resurfacing System by Japan's Ministry of Health, Labor and Welfare. Wright's CONSERVE(R) Plus System will expand the treatment options Japanese surgeons may offer their patients by providing a conservative, anatomically-focused surgical alternative to traditional hip replacement.

Hip resurfacing with Wright's CONSERVE(R) Plus System may be an ideal option for young, active patients suffering from chronic hip pain. In suitable patients, resurfacing allows the painful area of the hip joint to be surgically treated while retaining as much...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook